SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/09/22 BioCardia, Inc. 8-K:2,9 11/09/22 12:275K RDG Filings/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 27K 2: EX-99.1 Miscellaneous Exhibit HTML 95K 7: R1 Document And Entity Information HTML 50K 10: XML IDEA XML File -- Filing Summary XML 12K 8: XML XBRL Instance -- bcda20221108_8k_htm XML 17K 9: EXCEL IDEA Workbook of Financial Reports XLSX 8K 4: EX-101.DEF XBRL Definitions -- bcda-20221109_def XML 42K 5: EX-101.LAB XBRL Labels -- bcda-20221109_lab XML 54K 6: EX-101.PRE XBRL Presentations -- bcda-20221109_pre XML 41K 3: EX-101.SCH XBRL Schema -- bcda-20221109 XSD 16K 11: JSON XBRL Instance as JSON Data -- MetaLinks 14± 21K 12: ZIP XBRL Zipped Folder -- 0001437749-22-026593-xbrl Zip 27K
i BIOCARDIA, INC.
|
(Exact name of registrant as specified in its charter)
|
i Delaware
|
i 0-21419
|
i 23-2753988
|
||
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
i 320 Soquel Way
i Sunnyvale, i California i 94085 |
|
(Address of principal executive offices and zip code)
|
i ☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
i ☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
i ☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
i ☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which
registered
|
i Common Stock, par value $0.001
|
i BCDA
|
The i Nasdaq Capital Market
|
i Warrant to Purchase Common Stock
|
i BCDAW
|
The i Nasdaq Capital Market
|
Item 2.02.
|
Results of Operations and Financial Condition.
|
Item 9.01
|
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
|
99.1
|
||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
BIOCARDIA, INC.
|
|
President and Chief Executive Officer
|
|
Date: November 9, 2022
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 11/9/22 | 10-Q | ||
9/30/22 | 10-Q, 4 | |||
List all Filings |